The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RYZ101 (225Ac-DOTATATE) in patients with estrogen receptor-positive, human epidermal growth factor receptor 2–negative, locally advanced and unresectable, or metastatic breast cancer progressing after prior therapy: The phase 1b/2 TRACY-1 study.
 
Erica Mayer
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis
 
Kathy Miller
Consulting or Advisory Role - Celcuity; Genentech/Roche; Merck
Research Funding - Genentech (Inst); Radionetics (Inst); RayzeBio (Inst)
 
Komal Jhaveri
Consulting or Advisory Role - Abbvie; AstraZeneca; Bicycle Therapeutics; Biotheranostics; BluePrint Medicines; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Genentech; Gilead Sciences; Lilly; Novartis; Pfizer; Sanofi; Scorpion Therapeutics; Seagen
Research Funding - AstraZeneca (Inst); Blueprint Medicines (Inst); Context Therapeutics (Inst); Genentech (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); RayzeBio (Inst); Scorpion Therapeutics (Inst); VelosBio/Merck (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche; Gilead Sciences; Intellisphere; Jounce Therapeutics; Lilly; Pfizer; Taiho Pharmaceutical
 
Randy Yeh
No Relationships to Disclose
 
Elizabeth Sakach
No Relationships to Disclose
 
Vikas Prasad
Consulting or Advisory Role - Bayer HealthCare Pharmacuticals; Cellectar; Curium Pharma; Lantheus Medical Imaging; Lilly; Telix Pharmaceuticals
Speakers' Bureau - Curium Pharma
Travel, Accommodations, Expenses - RayzeBio; Telix Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - ECOG-ACRIN; ENETS; ESMO; ICPO Foundation; SNMMI
 
Denis Ferreira
Employment - RayzeBio
Stock and Other Ownership Interests - RayzeBio
 
Paul Herszdorfer
Employment - RayzeBio
Stock and Other Ownership Interests - RayzeBio
 
Lucy Gong
Employment - RayzeBio
Stock and Other Ownership Interests - RayzeBio
 
Joanne Li
Employment - RayzeBio
Stock and Other Ownership Interests - RayzeBio
 
Lisa Bodei
Consulting or Advisory Role - Wren Laboratories
Research Funding - AAA/Endocyte/Novartis (Inst); AAA/Endocyte/Novartis (Inst); Abdera Thereapeutics (Inst); Advanced Accelerator Applications/Novartis (Inst); Fusion Pharmaceuticals (Inst); ITM Isotope Technologies Munich (Inst); Molecular Targeting Technologies (Inst); POINT Biopharma (Inst); RayzeBio (Inst)
(OPTIONAL) Uncompensated Relationships - AAA/Endocyte/Novartis; Amgen; Clovis Oncology; Fusion Pharmaceuticals; Great Point Partners; IBA RadioPharma Solutions; ITM Isotope Technologies Munich; Molecular Targeting Technologies; POINT Biopharma; RayzeBio
 
Gary Ulaner
Honoraria - GE Healthcare; Lantheus Medical Imaging
Consulting or Advisory Role - GE Healthcare; ImaginAb; Lantheus Medical Imaging; POINT Biopharma
Speakers' Bureau - GE Healthcare; Lantheus Medical Imaging
Research Funding - GE Healthcare; Genentech; Lantheus Medical Imaging
Expert Testimony - GE Healthcare
Travel, Accommodations, Expenses - Lantheus Medical Imaging